Detalhe da pesquisa
1.
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Lancet Oncol
; 24(6): 611-623, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269842
2.
The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium.
Cancer Sci
; 112(3): 1095-1104, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393133
3.
NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma.
Cancer
; 126(16): 3674-3688, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32497261
4.
Global comparison of cancer outcomes: standardization and correlation with healthcare expenditures.
BMC Public Health
; 19(1): 1065, 2019 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31391013
5.
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
Cancer
; 123(21): 4147-4157, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28662313
6.
Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
Int J Cancer
; 136(4): E127-35, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25196065
7.
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.
Cancer
; 121(8): 1328-38, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25529384
8.
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
Cancer
; 121(16): 2720-9, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25946469
9.
Docetaxel chemotherapy for Chinese patients with castrate-resistant prostate cancer.
Hong Kong Med J
; 19(3): 237-41, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23568936
10.
First-line maintenance therapy with niraparib in advanced platinum-sensitive ovarian cancer: two 'long responder' case reports and review of the current literature.
J Int Med Res
; 51(9): 3000605231194881, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676922
11.
Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
JAMA Netw Open
; 6(7): e2323890, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459093
12.
A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer.
Sci Rep
; 12(1): 3803, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264616
13.
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Primary results from PALOMA-4.
Eur J Cancer
; 175: 236-245, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36155117
14.
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma.
Clin Cancer Res
; 28(12): 2679-2689, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381064
15.
Application of hypoglossal nerve constraint in definitive radiotherapy for nasopharyngeal carcinoma: A dosimetric feasibility study.
Med Dosim
; 46(1): 39-44, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32768273
16.
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.
Clin Cancer Res
; 27(17): 4848-4858, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108184
17.
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
Clin Cancer Res
; 27(23): 6413-6423, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433653
18.
Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse.
Expert Rev Mol Diagn
; 20(11): 1149-1159, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33040630
19.
Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG.
Oral Oncol
; 111: 105012, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32980659
20.
Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy.
Asia Pac J Clin Oncol
; 15(1): 48-55, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29932287